Literature DB >> 18239262

Altered vascular homeostasis in chronic kidney disease.

Narisa Futrakul1, Punnee Butthep, Prasit Futrakul.   

Abstract

Current treatments of chronic kidney disease (CKD) patients frequently result in progressive decline in renal perfusion, leading to the end-stage renal disease. Such renal failures may be a reflection of the progressive nature of renal microvascular disease. The aim of the present study is to elucidate the mechanism of microvascular homeostasis in CKD patients with moderately impaired renal function. We determined biomarkers relevant to vascular homeostasis, such as circulating endothelial cell (CEC), and biomarkers of vascular repair, such as vascular endothelial growth factor (VEGF), angiopoietin-1, tie-2, angiopoietin-2 and VEGF-R2. The present result revealed an enhanced vascular injury which was reflected by increased number of circulating endothelial cells. In addition, a defective vascular repair was also reflected by deficiencies in angiogenic factors such as VEGF, and angiopoietin-1, whereas the anti-angiogenic factors such as angiopoietin-2 and VEGF-R2 were elevated. In conclusion, the activity against vascular injuries increased under the presence of defective ability of vascular repair in CKD with moderately impaired renal function. This finding may explain the present therapeutic failure in treating these CKD patients, and imply that treatment at an earlier stage of CKD should be implemented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239262

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  25 in total

1.  Urgent call for reconsideration of chronic kidney disease.

Authors:  Narisa Futrakul; Prasit Futrakul
Journal:  World J Nephrol       Date:  2012-12-06

2.  Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.

Authors:  Erika Guise; Jason E Engel; Maxx L Williams; Fakhri Mahdi; Gene L Bidwell; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-20

Review 3.  Hypoxia and Dysregulated Angiogenesis in Kidney Disease.

Authors:  Shinji Tanaka; Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Kidney Dis (Basel)       Date:  2015-04-15

Review 4.  VEGF therapy for the kidney: emerging strategies.

Authors:  Erika Guise; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2018-02-14

5.  Elevated plasma levels of endostatin are associated with chronic kidney disease.

Authors:  Jing Chen; L Lee Hamm; Myra A Kleinpeter; Fred Husserl; Islam Enver Khan; Chung-Shiuan Chen; Yanxi Liu; Katherine T Mills; Chuan He; Nader Rifai; Eric E Simon; Jiang He
Journal:  Am J Nephrol       Date:  2012-03-27       Impact factor: 3.754

6.  Effects of Huanshuai Recipe Oral Liquid on restructuring glomerular microvasculature and expression of vascular endothelial growth factor in subtotal nephrectomized rats.

Authors:  Shen Li; Xiang-rong Rao; Jin-ye Song; Li-qiang Meng; Lei Qu; Xiao-mei Li
Journal:  Chin J Integr Med       Date:  2010-08-08       Impact factor: 1.978

Review 7.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

Review 8.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

9.  Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis.

Authors:  Tianfu Wu; Yong Du; Jie Han; Sandeep Singh; Chun Xie; Yuyuan Guo; Xin J Zhou; Chul Ahn; Ramesh Saxena; Chandra Mohan
Journal:  Mol Cell Proteomics       Date:  2013-01-23       Impact factor: 5.911

10.  A systematic review and participant-level meta-analysis found little association of retinal microvascular caliber with reduced kidney function.

Authors:  Weng Kit Lye; Euan Paterson; Christopher C Patterson; Alexander P Maxwell; Riswana Banu Binte Mohammed Abdul; E Shyong Tai; Ching Yu Cheng; Takamasa Kayama; Hidetoshi Yamashita; Mark Sarnak; Michael Shlipak; Kunihiro Matsushita; Unal Mutlu; Mohammad A Ikram; Caroline Klaver; Annette Kifley; Paul Mitchell; Chelsea Myers; Barbara E Klein; Ronald Klein; Tien Y Wong; Charumathi Sabanayagam; Gareth J McKay
Journal:  Kidney Int       Date:  2020-08-15       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.